Literature DB >> 12052805

Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough?

Merel C Van Maarle1, Marlies E A Stouthard, Perla J Marang-Van De Mheen, Niek S Klazinga, Gouke J Bonsel.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12052805      PMCID: PMC115213          DOI: 10.1136/bmj.324.7350.1367

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  [Tracing of patients with familial hypercholesterolemia in the Netherlands].

Authors:  M A Umans-Eckenhausen; J C Defesche; R L Scheerder; F Cliné; J J Kastelein
Journal:  Ned Tijdschr Geneeskd       Date:  1999-05-29

2.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

3.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

  3 in total
  3 in total

1.  Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial.

Authors:  Ruth Webster; Stephen Ch Li; David R Sullivan; Kathy Jayne; Steve Ys Su; Bruce Neal
Journal:  J Med Internet Res       Date:  2010-09-13       Impact factor: 5.428

2.  Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated.

Authors:  Trond P Leren; Knut Erik Berge
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

3.  Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis.

Authors:  Fiona J Kinnear; Elaine Wainwright; Rachel Perry; Fiona E Lithander; Graham Bayly; Alyson Huntley; Jennifer Cox; Julian Ph Shield; Aidan Searle
Journal:  BMJ Open       Date:  2019-07-31       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.